Grupo Casa Saba Announces Fourth Quarter 20...( Sales and Operating Income Plus Dep...),Health

Sales and Operating Income Plus Depreciation and Amortization Increased

3.85% and 2.96%, Respectively

MEXICO CITY, Feb. 26 /PRNewswire-FirstCall/ -- Grupo Casa Saba ("Saba", "GCS", "the Company" or "the Group"), one of the leading Mexican distributors of pharmaceutical products, beauty aids, personal care and consumer goods, general merchandise, publications and other products, announces its consolidated financial and operating results for the fourth quarter of 2007.

Financial Highlights:

(All figures are expressed in millions of Mexican pesos as of December 31, 2007. Comparisons are made with the same period of 2006, unless otherwise stated. Figures may vary due to rounding practices. "b.p." stands for basis points.)

- Sales for the quarter totaled $7,101.73 million

- Gross income increased 3.56%

- Gross margin for the quarter was 11.19%

- Quarterly operating expenses as a percentage of sales were 5.33%

- The operating margin for the quarter was 5.86%

- Net profit for the quarter reached $383.90 million

- Cash and cash equivalents at the end of the quarter was $661.63 million

QUARTERLY EARNINGS

NET SALES

During the fourth quarter, GCS's sales were $7,101.73 million, an increase of 3.85%.

Sales for our Private Pharma division grew 3.66% during the fourth quarter of 2007, due to an increase in the number of units sold.

Sales in our Health, Beauty, Consumer Goods, General Merchandise and Others division rose slightly versus the fourth quarter of 2006, growing 1.63%, while the Government Pharma division's sales increased 4.13%.

Publications sales increased significantly, growing by 14.62%. This was due to a significant increase in the number of units sold, particularly in sales of men's and women's magazines as well as health-oriented publications and the 2008 astrological guides.

The sales mix wa
'/>"/>